News
Important Only
Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Jan 6 (Reuters) - Transcode Therapeutics Inc RNAZ.O:TRANSCODE THERAPEUTICS INC - TTX-MC138 PHASE 2A CLINICAL TRIAL EXPECTED IN FIRST HALF OF 2026 - SEC FILINGSource text: [ID:n0001104659-26-001097]Reuters
Tue, Jan 6
Johnson & Johnson Submits Application To The European Medicines Agency For Tecvayli®▼
Jan 6 (Reuters) - Johnson & Johnson JNJ.N:JOHNSON & JOHNSON SUBMITS APPLICATION TO THE EUROPEAN MEDICINES AGENCY FOR TECVAYLI®▼ (TECLISTAMAB) IN COMBINATION WITH DARZALEX® (DARATUMUMAB) SUBCUTANEOUS FORMULATION FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMASource text: [ID:]Reuters
Tue, Jan 6
Dell Introduces Dell UltraSharp 52 Thunderbolt Hub Monitor & Dell UltraSharp 32 4K QD-OLED Monitor
Jan 6 (Reuters) - Dell Technologies Inc DELL.N:DELL: INTRODUCING DELL ULTRASHARP 52 THUNDERBOLT HUB MONITOR & DELL ULTRASHARP 32 4K QD-OLED MONITORDELL: DELL ULTRASHARP 52 THUNDERBOLT HUB MONITOR PRICED AT $2,899.99 (WITH STAND) & $2,799.99 (WITHOUT STAND), WILL BE AVAILABLE GLOBALLY BEGINNI...Reuters
Tue, Jan 6
Eli Hazum Resigned As Chief Executive Officer Of Regentis Biomaterials Ltd
Jan 6 (Reuters) - Regentis Biomaterials Ltd RGNT.A:REGENTIS BIOMATERIALS LTD - ON DECEMBER 31, 2025, ELI HAZUM RESIGNED AS CHIEF EXECUTIVE OFFICER OF REGENTIS BIOMATERIALS LTDREGENTIS BIOMATERIALS LTD - APPOINTED EHUD GELLER AS CHIEF EXECUTIVE OFFICERSource text: [ID:n0001213900-26-001588]Reuters
Tue, Jan 6
Libertystream Infrastructure Partners Plans Bulk Sampling
Jan 6 (Reuters) - LibertyStream Infrastructure Partners Inc LIB.V:LIBERTYSTREAM INFRASTRUCTURE PARTNERS: PLANS BULK SAMPLING AND OFFTAKE DISCUSSIONS FOR 2026, TARGETING COMMERCIAL VOLUMES BEGINNING 2027LIBERTYSTREAM INFRASTRUCTURE PARTNERS INC - PLANS TO INITIATE OFFTAKE DISCUSSIONS WITH STRATEGIC P...Reuters
Tue, Jan 6
Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting
Jan 6 (Reuters) - Ernexa Therapeutics Inc ERNA.O:ERNEXA THERAPEUTICS ANNOUNCES SUCCESSFUL PRE-IND FDA MEETING AND CONTINUES PROGRESS TOWARD FIRST-IN-HUMAN TRIAL IN OVARIAN CANCERERNEXA THERAPEUTICS INC - ON TRACK TO INITIATE FIH TRIAL FOR OVARIAN CANCER IN 2026Reuters
Tue, Jan 6
Terumo Launches Surtract™ Safety Syringe In The United States
Jan 6 (Reuters) - Terumo Corp 4543.T:TERUMO LAUNCHES SURTRACT™ SAFETY SYRINGE IN THE UNITED STATES, POWERED BY RONCADELLE OPERATIONS' SAFER® PASSIVE SAFETY TECHNOLOGYTERUMO MEDICAL CORP- SURTRACT SYRINGE DISTRIBUTION BEGINS IN Q1 2026Reuters
Tue, Jan 6
Kraneshares' Public-Private Fund Agix Increases Ownership In Elon Musk-Backed Xai
Jan 6 (Reuters) - KraneShares Artificial Intelligence and Tcnlgy ETF AGIX.O:KRANESHARES' PUBLIC-PRIVATE FUND AGIX INCREASES OWNERSHIP IN ELON MUSK-BACKED XAIKRANESHARES - AS OF JANUARY 2, 2026, XAI REPRESENTS 6.60% OF AGIX'S PORTFOLIOKRANESHARES - AGIX ALSO MAINTAINS A SIGNIFICANT PRIVATE IN...Reuters
Tue, Jan 6
Scantech Ai Systems Provides Update On Nasdaq Trading And Ongoing Restructuring Discussions
Jan 6 (Reuters) - ScanTech AI Systems Inc STAI.O:SCANTECH AI SYSTEMS PROVIDES UPDATE ON NASDAQ TRADING, HEARINGS PROCESS, AND ONGOING RESTRUCTURING DISCUSSIONSSCANTECH AI SYSTEMS INC - IN DISCUSSIONS WITH CREDITORS ON RESTRUCTURINGReuters
Tue, Jan 6
TPG in talks to buy UnitedHealth's Optum UK unit, Sky News reports
Jan 6 (Reuters) - U.S. private equity firm TPG TPG.O is close to acquiring UnitedHealth's UNH.N Optum UK business, in a deal worth between 1.2 billion pounds ($1.62 billion) and 1.4 billion pounds, Sky News reported on Tuesday.The deal could be announced in the coming weeks but has not yet been ...Reuters
Tue, Jan 6
